METTL14 and nonpapillary renal cell carcinoma: In recent years, the technique of adeno‐associated virus (AAV) has been successfully developed for gene delivery and used in therapeutic trials for various diseases,60, 61, 62 and could potentially be used to restore METTL14 and ZFP14 in ccRCC in the future.